Home Biosimilar Antibodies Apoptosis TNF-alpha antibody Certolizumab (Anti-TNFSF2 / TNFa) For research use only.
Not for use in humans.

Certolizumab (Anti-TNFSF2 / TNFa)

Synonyms:

Certolizumab (anti-TNFSF2 / TNFa) is a Fab fragment of a recombinant, humanized monoclonal antibody directed against the proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) with anti-inflammatory activity. MW: 144.92 kD.

Certolizumab (Anti-TNFSF2 / TNFa)

Purity & Quality Control

≥99

Choose Selective TNF-alpha Inhibitors

Biological Activity

Description Certolizumab (anti-TNFSF2 / TNFa) is a Fab fragment of a recombinant, humanized monoclonal antibody directed against the proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) with anti-inflammatory activity. MW: 144.92 kD.

Product Details

CAS No. 428863-50-7
Molecular Weight 144.92
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Certolizumab (Anti-TNFSF2 / TNFa) | Certolizumab (Anti-TNFSF2 / TNFa) supplier | purchase Certolizumab (Anti-TNFSF2 / TNFa) | Certolizumab (Anti-TNFSF2 / TNFa) cost | Certolizumab (Anti-TNFSF2 / TNFa) manufacturer | order Certolizumab (Anti-TNFSF2 / TNFa) | Certolizumab (Anti-TNFSF2 / TNFa) distributor